Managed post-market evidence reviews
Phase IV, Drug Safety and HEOR Evidence Reviews in Days, Not Months
ScitoVation rapidly finds, verifies and interprets the published evidence surrounding a defined post-market question without waiting months for a traditional literature review.
Defined-Scope ReviewsSource-Linked FindingsExpert VerificationDecision-Ready Reporting
A decision-ready answer
Get a Clear Answer to a Defined Post-Market Question
ScitoVation organizes the literature around the product, population, outcome and decision, then provides the scientific interpretation needed to support drug-safety, HEOR and Phase IV planning.
This managed service does not replace ongoing pharmacovigilance surveillance, case processing, signal management or regulatory reporting.
Questions answered
Questions the Review Can Address
What does the evidence show about a potential adverse event?
Do outcomes differ within a defined patient population?
Which populations respond better, worse or differently?
What factors influence adherence or discontinuation?
What is known about utilization, cost or economic burden?
Which evidence gaps should inform a Phase IV study?
Built for real decisions
Where This Service Fits
Drug-safety and adverse-event evidence reviews
Safety and effectiveness in special populations
Phase IV planning and evidence-gap assessment
Real-world evidence landscape reviews
Comparative-effectiveness evidence synthesis
HEOR, adherence, utilization and outcomes reviews
A transparent workflow
A Faster Path From Question to Evidence-Based Decision
Define the question
We confirm the product, population, outcome, sources and decision context.
Identify the evidence
We search and screen relevant scientific and medical literature.
Structure and verify findings
AI accelerates processing while scientists perform verification and quality control.
Interpret the evidence base
Scientists evaluate consistency, limitations, uncertainty and applicability.
Deliver the report
You receive the synthesis, sources, limitations, gaps and recommended actions.
Fast, clearly scoped work
Rapid Reviews With Scientific Oversight
Many clearly scoped evidence reviews can be completed in 2–5 business days. Broader reviews are scheduled according to evidence volume, full-text access, required methods and depth of evaluation.
Practical outputs
What You Receive
A focused, expert-reviewed evidence report
Structured, source-linked study findings
Documented screening, extraction and quality-control decisions
Assessment of uncertainty, conflicting evidence and limitations
A clear synthesis of safety, effectiveness or economic outcomes
Identified evidence gaps and recommended actions
Structured study tables or evidence exports when in scope
Common questions
Frequently Asked Questions
Does this replace ongoing pharmacovigilance surveillance?
No. This is a project-based service for defined Phase IV, drug-safety and HEOR questions.
Is this a self-service platform?
No. ScitoVation provides a managed scientific service.
How is AI used?
AI supports bounded information-processing tasks. Scientists remain responsible for verification and interpretation.
How quickly can a review be completed?
Many clearly scoped reviews can be delivered in 2–5 business days.
Bring Us the Product, Population, Outcome and Question
ScitoVation will recommend the appropriate evidence-review scope, confirm the timeline and explain what the completed review can support.